BBHC
VTYX

Brown Brothers Harriman & Co’s Ventyx Biosciences VTYX Stock Holding History

Brown Brothers Harriman & Co’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,845
Closed -$15.6K – 1241
2024
Q1 		$15.6K Buy
+2,845
New +$13K ﹤0.01% 935

Other funds holding VTYX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brown Brothers Harriman & Co's VTYX Position: Q2 2024 in Review

Brown Brothers Harriman & Co sold out of Ventyx Biosciences (VTYX) in Q2 2024, closing a stake of 2,845 shares — an estimated $15.6K sold.

Brown Brothers Harriman & Co first reported a position in VTYX in Q1 2024 and held it in 1 quarter. The position peaked at $15.6K in Q1 2024. 117 funds tracked by Wall St. Rank hold VTYX as of Q2 2024.

  • Brown Brothers Harriman & Co reported no remaining Ventyx Biosciences position as of Q2 2024 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 2,845 Ventyx Biosciences shares in Q2 2024, an estimated $15.6K.
  • Brown Brothers Harriman & Co first reported a position in Ventyx Biosciences in Q1 2024 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Ventyx Biosciences position peaked at $15.6K in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2024.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2024, filed 9 Aug 2024.